In an MCF-7 breast cancer cell model, PIK3C3 was found to stimulate ERK pathway-related tumor progression through protein kinase C-δ (PKC-δ)-mediated activation of p62 [108] (Figure 2). Here, PIK3C3 is linked to breast cancer.